Mini Review
Published on 03 Nov 2022
Ferroptosis: A new therapeutic target for bladder cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1043283
- 6,599 views
- 29 citations
101 articles related to "Bladder Cancer Bc"
Articles
Perspective
Published on 15 Feb 2021
Can new immunoassay techniques improve bladder cancer diagnostics With protein biomarkers?
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2020.620687
- 4,285 views
- 4 citations
Review
Published on 15 Jul 2022
Clinical potential of the Hippo-YAP pathway in bladder cancer
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.925278
- 6,194 views
- 11 citations
PDF-read only
Systematic Review
Published on 06 Nov 2023
Genetic Polymorphisms Involved in Bladder Cancer: A Global Review
Oncology Reviews
doi 10.3389/or.2023.10603
Mini Review
Published on 09 Aug 2024
Urinary mRNA-based biomarkers for non-muscle-invasive bladder cancer: a mini-review
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1441883
- 4,038 views
- 4 citations
Review
Published on 18 Nov 2019
Epigenetics of Bladder Cancer: Where Biomarkers and Therapeutic Targets Meet
in Epigenomics and Epigenetics
Frontiers in Genetics
doi 10.3389/fgene.2019.01125
- 14,257 views
- 41 citations
Original Research
Published on 22 Jul 2021
KCNMB2-AS1 Promotes Bladder Cancer Progression Through Sponging miR-374a-3p to Upregulate S100A10
in Cancer Genetics
Frontiers in Genetics
doi 10.3389/fgene.2021.655569
- 3,592 views
- 13 citations
Mini Review
Published on 11 Jan 2022
Current Advances in N6-Methyladenosine Methylation Modification During Bladder Cancer
in Epigenomics and Epigenetics
Frontiers in Genetics
doi 10.3389/fgene.2021.825109
- 6,214 views
- 20 citations
Original Research
Published on 11 Mar 2022
Conflicting Roles of ZFP36L1 in Regulating the Progression of Muscle Invasive Bladder Cancer
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2022.687786
- 4,338 views
- 2 citations
Original Research
Published on 06 Aug 2021
CD86 Molecule Might Be a Novel Immune-Related Prognostic Biomarker for Patients With Bladder Cancer by Bioinformatics and Experimental Assays
in Cancer Genetics
Frontiers in Oncology
doi 10.3389/fonc.2021.679851
- 4,800 views
- 6 citations
Original Research
Published on 20 Aug 2021
A Novel Ferroptosis-Related Prognostic Signature Reveals Macrophage Infiltration and EMT Status in Bladder Cancer
in Cell Death and Survival
Frontiers in Cell and Developmental Biology
doi 10.3389/fcell.2021.712230
- 10,763 views
- 30 citations
Original Research
Published on 14 May 2024
Investigation toward the economic feasibility of personalized medicine for healthcare service providers: the case of bladder cancer
in Precision Medicine
Frontiers in Medicine
doi 10.3389/fmed.2024.1388685
- 3,508 views
- 9 citations
Original Research
Published on 27 Aug 2025
A novel prognostic biomarker DUSP6 promote the malignant progression of bladder cancer through mTOR mediated mitophagy
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1603069
- 1,647 views
Review
Published on 12 Jan 2026
The infection–microbiome–immunity axis in bladder cancer: mechanistic insights and therapeutic perspectives
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1716230
- 1,213 views
Mini Review
Published on 04 Dec 2025
Evolving frontiers in bladder cancer immunotherapy: integrating BCG, immune checkpoints, viral vectors, nanotechnology, and CAR-based therapies
in Cancer Cell Biology
Frontiers in Cell and Developmental Biology
doi 10.3389/fcell.2025.1719978
- 1,899 views
Review
Published on 13 Nov 2024
Tumor-associated macrophages in bladder cancer: roles and targeted therapeutic strategies
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1418131
- 7,434 views
- 13 citations